2019 International Congress

Monday, September 23, 2019

1:45pm-3:15pm

Trihexyphenidyl-induced chorea in a patient with spastic torticollis: A case report

H. Kawasaki, O. Oota, S. Seo, K. Kei, T. Mistufuji, K. Takahashi, N. Tamura, T. Yamamoto (Moroyama, Japan)

Choreas (Non-Huntington’s Disease)  ·  Les Muses, Level 3

1:45pm-3:15pm

Tumor Pathology in Patients with Huntington’s Disease in a Specialized Center of Buenos Aires, Argentina (Preliminary Data)

D. Dias, E. Gatto, J. Etcheverry, M. Cesarini, G. da Prat, F. Peralta Calderon (Capital Federal, Argentina)

Huntington’s Disease  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Turkish Version of the Johns Hopkins Restless Leg Syndrome Quality of Life Questionnaire (RLS-QOL): Validity and Reliability Study

S. Güler, N. Turan (Edirne, Turkey)

Restless Leg Syndrome, RBD and Other Sleep Disorders  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Two heterozygous SNYE1 mutations presenting as spasmodic adductor dysphonia, task-specific jaw dystonia, generalized dystonia, and ataxia in a Jamaican man

E. Feinstein, P. Surathi (Newark, NJ, USA)

Ataxia  ·  Les Muses, Level 3

1:45pm-3:15pm

Two novel ANO10 mutations causing adult-onset autosomal recessive spinocerebellar ataxia

B. Bergmans, S. Donatello, M. Pandolfo, C. Depondt (Brugge, Belgium)

Ataxia  ·  Les Muses, Level 3

1:45pm-3:15pm

Two-year outcome of autologous peripheral nerve grafting to the substantia nigra at the time of DBS surgery in patients with Parkinson’s disease

C. van Horne, J. Quintero, J. Slevin, J. Gurwell, Z. Guduru, A. Welleford, N. El Seblani, G. Gerhardt (Lexington, KY, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Understanding the Needs and Concerns of Newly Diagnosed People with Parkinson’s Disease

V. Todaro, M. Feeney, A. Diaz, S. Rosenfeld, J. Gannon (New York, NY, USA)

Quality of Life  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Unilateral delivery of cell-based therapy to the putamen and substantia nigra in patients with Parkinson’s disease who have an existing DBS system

J. Quintero, J. Slevin, Z. Guduru, J. Gurwell, G. Gerhardt, C. van Horne (Lexington, KY, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Update from the international MDSGene initiative: International team science to perform genotype-phenotype correlations for hereditary movement disorders

S. Petkovic, S. Schaake, J. Huang, H. Madoev, A. Rasheed, K. Lohmann, C. Klein, C. Marras (Luebeck, Germany)

Other  ·  Agora 2 West, Level 2

1:45pm-3:15pm

Use digital sensor and deep learning to evaluate motor performance in the D1PAM (LY3154207) phase 1B Parkinson’s disease clinical trial

Y. Li, Y. Guan, J. Wang, A. Calvin, J. Kyle, B. Miller (Indianapolis, IN, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3